Trial Profile
Metabolic Effect of Combined Telmisartan and Nifedipine CR Therapy in Patients with Essential Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Apr 2012
Price :
$35
*
At a glance
- Drugs Nifedipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 19 Apr 2012 New trial record